|Off risk is arriving at certainty of efficacious drug with market demand
All these people are in it to make money ; no one to challenge how
Casinos are better regulated than AIM companies
NOMADs are only interested in fees
|Oh, and AVIVA have a good reputation to preserve as well, with all their investor/policyholders.|
|I don't understand the term OFF RISK. Please enlighten. Thanks.
Why then the share purchases, and whats the point of the options. Does Neil Woodford have a reputation of doing what you suspect when so many rely on him to maximise their investments under his management. Or is he just another shark, or legally operating hood?
Does the Company Secretary and Nomad not have fiduciary duties to ensure that all shareholders interests are protected, and the millions spent on R&D over 20 years must produce a reasonable return? If companies sell their shareholders short, why do shareholders keep so quiet about it?|
There is a big game and history going on here. Go back to check some rocket fuel posts. The three institutions are ready to take this out the moment it is off risk. Why pay shmucks like you 20p when 4 or 5p will do if they keep it low? Chris Evans dealings stink; I made a little going out at 6.5 having built up from 2p
I could see it was then a game of salaries for MH & His CTO . This changed when Woodford got in and made sure he controls the shots . The two others will not admit, nod nod?|
|Will never understand why prices go up and down on such small trading volume - I mean there are over 3bn shares in issue. I topped up a little today thinking there's RP news due in first half of this year, maybe MH will want to speak about it in Edinburgh next week. Someone is holding this back, though how they do it when Woodford , Toscafund, and Aviva are aboard and positive about it, beats me. Also Olaf H the CEO spent £10,000 adding 346,644 shares on 14th Dec 2016 to make his total 669,422, and even Michael H who's speaking on Wednesday, bought another 250,000 this week taking him to a total of 2,008,471.
These two both have big share options exercisable subject to the achievement of the following performance conditions:
1) When the first patient is administered with a ReNeuron cell therapy in a sixth clinical trial, one third of the options will vest.
2) When the fourth clinical trial of a ReNeuron cell therapy completes, one third of the options will vest.
3) If the Total Shareholder Return (TSR) of the Company meets or exceeds that of the FTSE AIM Healthcare Index in any given three year period from the date of grant, one third of the options will vest.
The vesting criteria for the TSR-related performance condition above will also apply on a proportionate basis to TSR-related performance conditions attaching to prior share option grants under the LTIP.
Well, perhaps someone here understands what the above means and what the share price will have to be at before they get the big bucks. Olaf H's options pot amounts to 33m+ shares, and Michael H's pot is 29m+.
In the meantime they get big salaries while our shares languish in sweeties land. We already have come a long long way and are nearer, and getting nearer every day, to the good news outcomes the company was floated for at 25p back in Aug 2005 and reaching 46p in Jan 2007. Investors in those days must must have had a real long term vision for RENE. Hopefully our CEO and CFO have the same vision to turn our company share price back up to these dizzy levels, without selling us out to be gobbled up by the AZNs of this world, before adequate payback for the 20 years of loyalty.|
Some AIM companies have done OK; AMS IS ONE. HONEST MANAGEMENT STAYED HONEST. Others start honest but end up needing to fiddle to survive, so they bend it Yet others come to AIM to milk easy money , reducing the project risk till ripe to be bought in.
Rocket Fuel may be too close to the truth for comfort. He remembers the tricks played on investors including HMER ; (If they are not wasting the trial money and results are not negative you would expect the value to keep in step plus . This is now a huge upside bet for the funds. I got out at 6.5 years ago because I could smell the stench. I hope I am wrong because it would be great to reduce stroke sufferers misery and that of their folk and to do so honestly|
|You do wonder alimo .....you do wonder?|
|Rigged? I lost out big time on Renovo when the IP was lauded by many in the bio world and Phase 1&2 trials appeared to meet acceptable endpoints. Phase III trials did and then didn't(most confusing) and everything that was so promising and the glowing lost pipeline just disappeared mysteriously and wasn't worth buttons, after the tens of millions spent on development, and nobody was sent to jail! So what is being rigged, here, and for what purpose.
We have been told and have watched the video results of one of the people who has greatly improved mobility during the trials. Huge amounts of money have been invested. Are you saying that original investors who have not averaged down as the huge dilution has occurred, will never see a return on their investment? Or are you saying that the share price is being manipulated to help the wealthy get wealthier. OR will it be the big sickener, that just as all the research proves successful, and the future should be rosy (even for the original investors), the company is taken/bought out, and PIs denied any opportunity to increase their wealth. If AIM is such a fiddle, why is the small investor encouraged by brokers to invest, and why don't the company regulators do more to protect small shareholders from ruthless greed of the very wealthy?|
|more drops - guess im writing off my money in this one - and yet i totally believe in the products and processes....
It is sad that companies seek to go Public when they are not suited ; AIM has been a disaster barring less than a handful of situations.I hope you will not lose your money but it is beginning to look solidly rigged|
RENE presenting on Monday|
|more drops - guess im writing off my money in this one - and yet i totally believe in the products and processes....|
|Merry Christmas all and a happy, healthy and prosperous new year.
Whilst healthy is the most important, it would be nice to get an injection of proaperity.
Guess time will tell.
Good luck all.
|as over 50% of the stop is owned by 3 fund managers legally committed to ensuring this doesn't happen unless friendly and fair
Exactly; Its easily a done deal, perhaps with a small premium|
|Its a bit like doubting Thomas. Looks like market needs to be 100% certain, as currently no appetite for risk.Hopefully Renes 2017 results will calm fears. Time will tell|
|Rene cannot be taken out on the cheap, as over 50% of the stop is owned by 3 fund managers legally committed to ensuring this doesn't happen unless friendly and fair!|
|The share price is worrying for 2 reasons
1. Could it be that Rene is being prepared for a cheap takeout?
2. Could it be that progress is not rated by those in the know?|
|Cheers. The more patient stories the better.|
|Excellent patient driven article. Very positive and c/o flier lse site
I suspect the placebo will be done in the way it has for the trial of another neuro surgical procedure i.e. the placebo patients will be prepared for the surgical procedure and then have a small incision so that they are unaware that they haven't had the full procedure.
It is amazing how often there is a real placebo affect.
Having said that I have first hand experience of a close relative who has suffered a major stroke six months ago and would say that a 75% chance of some clinical improvement seems to be well worth trying given the only treatment option is physiotherapy with diminishing returns as time goes on.|